IP Library Granted Patent US 7,879,388
Granted Patent B2
US 7,879,388 · App. 11/665,529 · Granted Feb 1, 2011

Methods for production and use of synthetic hydroxyapatite and fluorapatite nanorods, and superstructures assembled from the same

Assignee: The Regents of the University of Michigan
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,879,388
App. No.
11/665,529
Granted
Feb 1, 2011
Kind
B2
Abstract

Disclosed herein are methods directed toward the synthesis of ordered structures of hydroxyapatite and hydroxyapatite derivatives. More specifically, disclosed herein is a method of preparing ordered hydroxyapatite nanorod structures including the steps of suspending calcium and phosphate in a solvent, adjusting the pH to above 5, and heating to a temperature sufficient to support formation of the ordered hydroxyapatite nanorod structures. In some cases, the methods may include ethylenediamine tetraacetic acid or ethylenediamine tetraacetic acid derivatives. Also disclosed are methods that additionally involve a step of coating hydroxyapatite nanorods with a protein or an amphiphile such as a surfactant or polymer.

Claims (45)

1. A method of preparing ordered hydroxyapatite nanorod structures comprising:

suspending or dissolving a calcium source, a phosphate source, and ethylenediaminetetraacetic acid or an ethylenediaminetetraacetic acid derivative in a solvent to form a suspension or a solution;

adjusting the suspension or solution to a pH in the range of about 6 to about 11; and

heating the suspension or solution to a temperature in the range of 25° C. to 150° C. at a pressure greater than 1 atm to support formation of the ordered hydroxyapatite nanorod structures,

wherein the suspension or solution further comprises amelogenin, enamelin, dentin phosphoprotein, collagen, or ameloblastin.

2. The method of claim 1 wherein the calcium source is selected from the group consisting of calcium phosphate, calcium nitrate, calcium ethylenediaminetetraacetate, calcium carbonate, calcium acetate, calcium bromide, calcium fluoride, calcium iodide, calcium chloride, calcium citrate, calcium hydroxide, calcium oxylate, calcium sulfate, calcium ethoxide, and combinations thereof.

3. The method of claim 1 wherein the phosphate source is selected from the group consisting of calcium phosphate, sodium phosphate, ammonium phosphate, lithium phosphate, potassium phosphate, magnesium phosphate, triethyl phosphate, and combinations thereof.

4. The method of claim 1 wherein both the calcium source and the phosphate source comprise powdered hydroxyapatite.

5. The method of claim 1 wherein the solvent is selected from the group consisting of water, methanol, ethanol, nitric acid and combinations thereof.

6. The method of claim 1 wherein the pH of the suspension or solution is adjusted to about 6.

7. The method of claim 1 wherein the temperature is in the range of 70° C. to 130° C.

8. The method of claim 1 wherein the heating persists for a time period in the range of about 5 minutes and about 120 hours.

9. The method of claim 1 wherein the suspension or solution further comprises ammonium fluoride or sodium fluoride to form fluorapatite structures.

10. The method of claim 1 further comprising exposing the suspension or solution to carbon dioxide.

11. The method of claim 10 wherein the carbon dioxide comprises atmospheric carbon dioxide.

12. The method of claim 1 wherein the hydroxyapatite nanorod structures comprise nanorods with a diameter in the range of about 5 nm to about 5 μm and a length in the range of about 10 nm to about 200 μm.

13. A method for producing an enamel film comprising:

a) suspending or dissolving a calcium source, a phosphate source, and ethylenediaminetetraacetic acid or an ethylenediaminetetraacetic acid derivative in a solvent to form a suspension;

b) adjusting the suspension or solution to a pH in the range of about 6 to about 11;

c) adding a substrate to the suspension or solution; and

d) heating the suspension or solution to a temperature in the range of 25° C. to 150° C. and under a pressure greater than 1 atm to form an enamel film on the substrate,

wherein the suspension or solution further comprises amelogenin.

14. The method of claim 13 wherein the substrate is a bone implant, dental implant, or dental restorative material.

15. The method of claim 13 wherein the temperature is in the range of 120° C. to 130° C. and the pressure is above 2 atm.

16. The method of claim 13 wherein the calcium source is selected from the group consisting of calcium phosphate, calcium nitrate, calcium ethylenediaminetetraacetate, calcium carbonate, calcium acetate, calcium bromide, calcium fluoride, calcium iodide, calcium chloride, calcium citrate, calcium hydroxide, calcium oxylate, calcium sulfate, calcium ethoxide, and combinations thereof.

17. The method of claim 13 wherein the phosphate source is selected from the group consisting of calcium phosphate, sodium phosphate, ammonium phosphate, lithium phosphate, potassium phosphate, magnesium phosphate, triethyl phosphate, and combinations thereof.

18. The method of claim 13 wherein both the calcium source and the phosphate source comprise powdered hydroxyapatite.

19. The method of claim 13 wherein the solvent is selected from the group consisting of water, methanol, ethanol, nitric acid and combinations thereof.

20. The method of claim 13 wherein the suspension or solution is adjusted to a pH in the range of 6 to 8.

21. The method of claim 13 wherein the heating persists for a time period in the range of about 10 hours and about 48 hours.

22. The method of claim 13 wherein the suspension or solution further comprises sodium fluoride or ammonium fluoride to form the enamel film comprising fluorapatite.

23. The method of claim 13 further comprising exposing the suspension or solution to carbon dioxide.

24. The method of claim 23 wherein the carbon dioxide comprises atmospheric carbon dioxide.

25. The method of claim 13 wherein the enamel film comprises nanorods with a diameter in the range of about 5 nm to about 5 μm and a length in the range of about 10 nm to about 200 μm.

26. A method of preparing ordered fluorapatite nanorod structures comprising:

suspending or dissolving a calcium source, a phosphate source, a fluoride source, and ethylenediaminetetraacetic acid or an ethylenediaminetetraacetic acid derivative in a solvent to form a suspension or a solution;

adjusting the suspension or solution to a pH in the range of about 6 to about 11; and

heating the suspension or solution to a temperature in the range of 25° C. to 150° C. to support formation of the ordered fluorapatite nanorod structures.

27. The method of claim 26 , wherein the calcium source is selected from the group consisting of calcium phosphate, calcium nitrate, calcium ethylenediaminetetraacetate, calcium carbonate, calcium acetate, calcium bromide, calcium fluoride, calcium iodide, calcium chloride, calcium citrate, calcium hydroxide, calcium oxylate, calcium sulfate, calcium ethoxide, and combinations thereof.

28. The method of claim 26 , wherein the phosphate source is selected from the group consisting of calcium phosphate, sodium phosphate, ammonium phosphate, lithium phosphate, potassium phosphate, magnesium phosphate, triethyl phosphate, and combinations thereof.

29. The method of claim 26 , wherein the fluoride source comprises ammonium fluoride or sodium fluoride.

30. The method of claim 26 , further comprising heating the suspension or solution under a pressure greater than 1 atm.

31. The method of claim 26 , wherein the temperature is in the range of 70° C. to 130° C.

32. The method of claim 26 , wherein the pH of the suspension or solution is about 6.

33. The method of claim 30 , wherein the pressure is 2 atm or greater.

Assignments (1)
CONFIRMATORY LICENSE Recorded Sep 23, 2008
From: UNIVERSITY OF MICHIGAN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021572/0913 →
Continuity (2)
Provisional Application 60622897 · Oct 28, 2004
Related Publication 20080220148A1 · Sep 11, 2008